HighMark Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.3K | Hold |
220
| – | – | 0.01% | 234 |
|
|
2025
Q1 | $17.9K | Sell |
220
-1,404
| -86% | -$114K | 0.01% | 206 |
|
|
2024
Q4 | $146K | Sell |
1,624
-599
| -27% | -$53.9K | 0.08% | 69 |
|
|
2024
Q3 | $220K | Hold |
2,223
| – | – | 0.12% | 61 |
|
|
2024
Q2 | $206K | Buy |
2,223
+3
| +0.1% | +$278 | 0.12% | 61 |
|
|
2024
Q1 | $211K | Hold |
2,220
| – | – | 0.13% | 58 |
|
|
2023
Q4 | $198K | Sell |
2,220
-25
| -1% | -$2.23K | 0.15% | 55 |
|
|
2023
Q3 | $164K | Hold |
2,245
| – | – | 0.14% | 50 |
|
|
2023
Q2 | $187K | Hold |
2,245
| – | – | 0.14% | 51 |
|
|
2023
Q1 | $171K | Hold |
2,245
| – | – | 0.13% | 61 |
|
|
2022
Q4 | $186K | Hold |
2,245
| – | – | 0.14% | 50 |
|
|
2022
Q3 | $178K | Hold |
2,245
| – | – | 0.15% | 51 |
|
|
2022
Q2 | $167K | Sell |
2,245
-575
| -20% | -$42.8K | 0.13% | 50 |
|
|
2022
Q1 | $253K | Hold |
2,820
| – | – | 0.17% | 44 |
|
|
2021
Q4 | $316K | Buy |
2,820
+2,575
| +1,051% | +$289K | 0.2% | 41 |
|
|
2021
Q3 | $31K | Buy |
+245
| New | +$31K | 0.02% | 146 |
|